Taylor, P., Bieber, T., Alten, R., Witte, T., Galloway, J., Deberdt, W., . . . Wollenberg, A. (2023). Baricitinib safety for events of special interest in populations at risk: Analysis from randomised trial data across rheumatologic and dermatologic indications. Springer Nature.
Chicago Style (17th ed.) CitationTaylor, PC, et al. Baricitinib Safety for Events of Special Interest in Populations at Risk: Analysis from Randomised Trial Data Across Rheumatologic and Dermatologic Indications. Springer Nature, 2023.
MLA (9th ed.) CitationTaylor, PC, et al. Baricitinib Safety for Events of Special Interest in Populations at Risk: Analysis from Randomised Trial Data Across Rheumatologic and Dermatologic Indications. Springer Nature, 2023.
Warning: These citations may not always be 100% accurate.